Recombinant Viruses


A recombinant vaccine is a vaccine developed through recombinant DNA technology. Vaccine approaches to contagious diseases are widely applied and appreciated. Amongst them, vectors based on recombinant viruses have displayed great promise and play a crucial role in the instigation of new vaccinations. Many viruses have been examined for their ability to express proteins from foreign pathogens and induce specific immunological responses against these antigens in vivo. Generally, gene-based vaccines can trigger potent humoral and cellular immune responses and viral vectors might be an effective strategy for both the delivery of antigen-encoding genes and the facilitation and enhancement of antigen presentation.


Recent methods in the diagnosis of viral infections:


Immunoassay-based tests


Amplification-based assays


Next-generation sequencing


Mass spectrometry

    Related Conference of Recombinant Viruses

    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic
    December 15-16, 2025

    7th Global Experts Meeting on Infectious Diseases

    Barcelona, Spain
    December 17-18, 2025

    17th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Recombinant Viruses Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in